Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Metabolomics Market Revenue Outlook: What CAGR Lies Ahead Through 2030?
The metabolomics market has undergone rapid expansion recently. Its value is anticipated to rise from $4.17 billion in 2025 to $4.9 billion in 2026, at a compound annual growth rate (CAGR) of 17.5%. This historical growth can be attributed to several factors including increasing research into biomarker discovery, wider acceptance of mass spectrometry, a surge in cancer metabolism studies, the expanding use of chromatography systems, and advancements in metabolite profiling techniques.
The metabolomics market is anticipated to experience significant expansion in the coming years. This market is projected to reach $9.29 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.3%. This projected growth during the forecast period is fueled by advancements in bioinformatics tools, a greater emphasis on personalized medicine, increased demand for nutrigenomics applications, expansion in metabolic pathway research, and broader integration of clinical diagnostics. Noteworthy trends for the forecast period encompass the integration of precision medicine with metabolomic profiling, the proliferation of cloud-based metabolomics data platforms, AI-powered metabolite pattern recognition, enhanced automation in high-throughput metabolomics workflows, and IoT-enabled real-time metabolic monitoring.
Get A Free Sample Report With In-Depth Market Insights:
Metabolomics Market Growth Catalysts And Demand Drivers
The increasing incidence of cancer is anticipated to drive the expansion of the metabolomics market in the coming years. Cancer is characterized as a group of diseases where abnormal cells proliferate uncontrollably, invade tissues, and can spread throughout the body. The escalation in cancer prevalence stems from an aging population, as advanced age represents the most significant risk factor for developing most forms of cancer, with the majority of diagnoses occurring in individuals over 65 years old. Metabolomics assists cancer research by offering a comprehensive overview of metabolic alterations in tumor cells, thereby enabling early detection, a deeper understanding of disease mechanisms, and the identification of potential therapeutic targets. For example, in February 2024, the World Health Organization, a Switzerland-based international entity focused on global health policy and public health initiatives, predicted that over 35 million new cancer cases are expected by 2050, signifying a 77% increase from the approximately 20 million cases estimated in 2022. Thus, the rising occurrence of cancers is a key factor propelling the growth of the metabolomics market.
Metabolomics Market Segmentation: How Does The Market Break Down By Category?
The metabolomics market covered in this report is segmented –
1) By Product And Service: Metabolomics Instruments, Metabolomics Bioinformatics Tools And Services
2) By Indication: Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors Of Metabolism, Other Indications
3) By Application: Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, Other Applications
Subsegments:
1) By Metabolomics Instruments: Chromatography Instruments (Gas Chromatography, Liquid Chromatography), Mass Spectrometry Instruments (LC-MS, GC-MS), NMR Instruments (Nuclear Magnetic Resonance)
2) By Metabolomics Bioinformatics Tools And Services: Software Tools (Data Analysis, Statistical Tools, Modeling Tools), Database Services (Metabolomic Databases), Consulting Services (Data Interpretation, Analytical Support), Training And Support Services
Metabolomics Market Trends Shaping Long-Term Demand
Leading companies within the metabolomics market are concentrating on introducing Integrated Bioinformatics Platforms to enhance the understanding of complex metabolomic data, consequently advancing personalized medicine, biomarker discovery, and disease insights. An Integrated Bioinformatics Platform is a complete software solution that integrates various bioinformatics tools and databases to streamline the analysis and interpretation of biological data. Researchers are able to index metabolomics data using Metabolon’s accurate biochemical pathway maps, which assists in revealing biological processes and disease mechanisms. For example, in February 2024, Metabolon, Inc., a US-based firm, unveiled its bioinformatics platform. The Biomarker Lenses feature in the Integrated Bioinformatics Platform allows users to employ advanced analytical filters to pinpoint metabolites connected to specific pathways or diseases, facilitating a more directed exploration of metabolomic data. Furthermore, the platform offers tools for conducting statistical analyses such as T-tests and ANOVAs, enabling researchers to develop and compare statistical models, manage metadata, and present results effectively.
Metabolomics Market Competitive Overview And Top Companies
Major companies operating in the metabolomics market are Human Metabolome Technologies Inc., Metabolon Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Agilent Technologies Inc., Thermo Fisher Scientific Inc., Waters Corporation, Biocrates Life Sciences AG, Shimadzu Corporation, Danaher Corporation, PerkinElmer Inc., LECO Corporation, Phenomenome Discoveries Inc., AB Sciex, BG Medicine Inc., Chenomx Inc., Creative Proteomics, Evotec A.G, Merck kgaA, Charles River Laboratories International Inc., Metabowerke GmbH, Metabolomic Diagnostics, Phenomenex Inc.
View The Full Metabolomics Market Report:
Metabolomics Market Global Footprint: Which Region Leads The Market?
North America was the largest region in the metabolomics market in 2025. Western Europe was the second largest region in the metabolomics market. The regions covered in the metabolomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
